Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: baggo who wrote (1263)	3/8/1998 10:23:00 PM
From: David S.	Read Replies (1) \| Respond to of 5736

this place is even getting too wierd for me.

To: baggo who wrote (1263)	3/9/1998 3:36:00 AM
From: Merg	Read Replies (1) \| Respond to of 5736

Dear Brice (or should I say Dr. Brice) My you are a touchy fellow. You must already be heavily invested and you have my sympathy. I suggest that it would be worth your while to visit the Neonatal intensive unit in your hospital and ask the nurse there to show you the device(s) that is already in STANDARD use in hospitals. If your hospital does not have one perhaps it is because it is the ONLY hospital in North America who doesn't already know that Bilirubin tests are done on ALL newborns admitted to or born in a hospital. Incidently did you ever see or hear of anyone 'dying' of kernicterus? It rarely (if ever) happens in the US. This is usually only associated with erythroblastosis faetalis, a problem that is prevented by RH testing of parents prior to birth of child. I'm sure if you ask that NICU nurse she'll explain it to you. Yes,IMO.. IF this device is accurate (maybe) and IF it is cost effective (not likely) and IF it were smaller than a suitcase (which it isn't) it might be useful in some circumstances. You do know of course that this would not be effective as a screening tool for Hepatitis C since this disease is often present in a person without symptoms of jaundice.